DiDi Global Stock-Based Compensation 2021-2025 | DIDIY
DiDi Global annual/quarterly stock-based compensation history and growth rate from 2021 to 2025. Stock-based compensation can be defined as the estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors
- DiDi Global stock-based compensation for the quarter ending March 31, 2025 was $0M, a 0% increase year-over-year.
- DiDi Global stock-based compensation for the twelve months ending March 31, 2025 was $0.313B, a 13.61% decline year-over-year.
- DiDi Global annual stock-based compensation for 2024 was $0.313B, a 13.61% decline from 2023.
- DiDi Global annual stock-based compensation for 2023 was $0.363B, a 26.93% decline from 2022.
- DiDi Global annual stock-based compensation for 2022 was $0.496B, a 87.17% decline from 2021.
| DiDi Global Annual Stock-Based Compensation (Millions of US $) |
|
|---|---|
| 2024 | $313 |
| 2023 | $363 |
| 2022 | $496 |
| 2021 | $3,869 |
| 2020 | $521 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $26.168B | $28.768B |
| DiDi Global Inc. provides mobility technology platform. It offers app-based services across Asia Pacific, Latin America and Africa as well as in Central Asia and Russia, including ride hailing, taxi hailing, chauffeur, hitch and other forms of shared mobility as well as auto solutions, food delivery, intra-city freight and financial services. DiDi Global Inc. is based in BEIJING. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $145.222B | 26.93 |
| CVS Health (CVS) | United States | $74.320B | 9.24 |
| Elevance Health (ELV) | United States | $63.147B | 8.49 |
| Cencora (COR) | United States | $56.296B | 19.58 |
| Labcorp Holdings (LH) | United States | $22.406B | 17.68 |
| Natera (NTRA) | United States | $19.262B | 0.00 |
| BioMerieux (BMXMF) | France | $15.985B | 0.00 |
| ICON (ICLR) | Ireland | $15.748B | 15.15 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $14.835B | 0.00 |
| CochLear (CHEOY) | Australia | $13.402B | 0.00 |
| Medpace Holdings (MEDP) | United States | $12.801B | 33.88 |
| Solventum (SOLV) | United States | $12.791B | 13.54 |
| Revvity (RVTY) | United States | $12.019B | 20.68 |
| Viatris (VTRS) | United States | $10.974B | 3.77 |
| Avantor (AVTR) | United States | $9.547B | 13.87 |
| Sonic Healthcare (SKHHY) | Australia | $9.287B | 0.00 |
| Charles River Laboratories (CRL) | United States | $8.698B | 17.05 |
| HealthEquity (HQY) | United States | $8.162B | 35.75 |
| Caris Life Sciences,�Inc (CAI) | United States | $7.502B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.943B | 29.10 |
| BrightSpring Health Services (BTSG) | United States | $3.632B | 33.32 |
| Sotera Health (SHC) | United States | $3.437B | 19.53 |
| Surgery Partners (SGRY) | United States | $2.693B | 35.02 |
| Organon (OGN) | United States | $2.618B | 2.78 |
| Concentras Parent (CON) | United States | $2.517B | 14.55 |
| GeneDx Holdings (WGS) | United States | $2.324B | 89.50 |
| Alignment Healthcare (ALHC) | United States | $2.303B | 0.00 |
| Progyny (PGNY) | United States | $1.972B | 43.40 |
| GoodRx Holdings (GDRX) | United States | $1.775B | 35.50 |
| Premier (PINC) | United States | $1.747B | 13.26 |
| PACS (PACS) | United States | $1.742B | 0.00 |
| Ardent Health (ARDT) | United States | $1.543B | 6.58 |
| Teladoc Health (TDOC) | United States | $1.439B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.248B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.067B | 8.12 |
| QDM (QDMI) | Hong Kong, SAR China | $0.997B | 342.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $0.970B | 0.00 |
| Agilon Health (AGL) | United States | $0.857B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.750B | 7.03 |
| CareDx (CDNA) | United States | $0.715B | 11.16 |
| Embecta (EMBC) | United States | $0.665B | 4.48 |
| Nutex Health (NUTX) | United States | $0.532B | 8.05 |
| InnovAge Holding (INNV) | United States | $0.513B | 0.00 |
| SBC Medicals (SBC) | United States | $0.505B | 0.00 |
| Omada Health (OMDA) | $0.486B | 0.00 | |
| LifeMD (LFMD) | United States | $0.485B | 0.00 |
| So-Young (SY) | China | $0.480B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.469B | 10.55 |
| Sonida Senior Living (SNDA) | United States | $0.463B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.409B | 0.00 |
| Enhabit (EHAB) | United States | $0.349B | 28.71 |
| Oncology Institute (TOI) | United States | $0.326B | 0.00 |
| Performant Healthcare (PHLT) | United States | $0.287B | 0.00 |
| Beauty Health (SKIN) | United States | $0.231B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.187B | 0.00 |
| DocGo (DCGO) | United States | $0.148B | 24.17 |
| Sera Prognostics (SERA) | United States | $0.122B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.083B | 0.00 |
| KindlyMD (NAKA) | United States | $0.080B | 0.00 |
| Biodesix (BDSX) | United States | $0.061B | 0.00 |
| NeueHealth (NEUE) | United States | $0.060B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.058B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.045B | 0.00 |
| ModivCare (MODV) | United States | $0.044B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.041B | 0.00 |
| OSR Holdings (OSRH) | United States | $0.019B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.010B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.009B | 0.00 | |
| SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
| INVO Fertility (IVF) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |